Industry Leaders

Javad Nazarian, PhD

Head of the Translational Program of the DIPG/DMG Center Zurich

Dr. Javad Nazarian leads cutting-edge research in childhood brain cancer as Head of the DIPG/DMG Research Center at the University Children’s Hospital in Zürich, focusing on developing treatments for diffuse midline gliomas (DMGs) and diffuse intrinsic pontine gliomas (DIPGs). His pioneering work in co-leading the DMG Adaptive Combinatorial Trial (DMG-ACT) has united 16 institutions across three continents and already led to two new clinical trials. Dr. Nazarian’s research has been pivotal in characterizing the molecular landscape of DMGs/DIPGs through protein profiling techniques, analyzing tumor evolution, and identifying new therapeutic targets, while also advancing innovative approaches in liquid biopsy and focused ultrasound studies.